A Pilot Open-Label Clinical Trial of CPI-613 in Patients With Advanced Bile Duct Cancers
Phase of Trial: Phase I/II
Latest Information Update: 06 Jun 2017
At a glance
- Drugs CPI 613 (Primary)
- Indications Cholangiocarcinoma
- Focus Therapeutic Use
- 06 Jun 2017 Results (n=14) presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 28 Dec 2015 Planned primary completion date changed from 1 May 2016 to 1 May 2017 as reported by ClinicalTrials.gov record.
- 23 Jun 2015 Planned primary completion date changed from 1 May 2015 to 1 May 2016 as reported by ClinicalTrials.gov record.